» Authors » Alexander Ring

Alexander Ring

Explore the profile of Alexander Ring including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 553
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurzeder C, Nguyen-Strauli B, Krol I, Ring A, Castro-Giner F, Nuesch M, et al.
Nat Med . 2025 Jan; PMID: 39856336
The presence of circulating tumor cell (CTC) clusters is associated with disease progression and reduced survival in a variety of cancer types. In breast cancer, preclinical studies showed that inhibitors...
2.
Ezedinma U, Jones E, Ring A, Miller S, Ladhams A, Fjaagesund S, et al.
Autism . 2024 Dec; :13623613241305721. PMID: 39673442
Methylenetetrahydrofolate reductase mutations refer to genetic variations in the methylenetetrahydrofolate reductase enzyme, which plays an important role in folate metabolism. Folate is essential for neural development and signalling. Children with...
3.
Thorne J, Hellewell S, Cowen G, Ring A, Jefferson A, Chih H, et al.
J Head Trauma Rehabil . 2024 Mar; 39(5):E381-E392. PMID: 38453632
Objectives: People may experience a myriad of symptoms after mild traumatic brain injury (mTBI), but the relationship between symptoms and objective assessments is poorly characterized. This study sought to investigate...
4.
Kaur P, Ring A, Porras T, Zhou G, Lu J, Kang I, et al.
Cancers (Basel) . 2024 Feb; 16(3). PMID: 38339267
Triple-negative breast cancer (TNBC) is characterized by an aggressive clinical presentation and a paucity of clinically actionable genomic alterations. Here, we utilized the Cancer Genome Atlas (TCGA) to explore the...
5.
Wildschut M, Mena J, Dordelmann C, van Oostrum M, Hale B, Settelmeier J, et al.
Nat Commun . 2023 Oct; 14(1):6414. PMID: 37828014
Myelofibrosis is a hematopoietic stem cell disorder belonging to the myeloproliferative neoplasms. Myelofibrosis patients frequently carry driver mutations in either JAK2 or Calreticulin (CALR) and have limited therapeutic options. Here,...
6.
Holler A, Nguyen-Strauli B, Frauchiger-Heuer H, Ring A
Breast Cancer (Dove Med Press) . 2023 Aug; 15:525-540. PMID: 37533589
Luminal breast cancers are hormone receptor (estrogen and/or progesterone) positive that are further divided into HER2-negative luminal A and HER2-positive luminal B subtypes. According to currently accepted convention, they represent...
7.
Ring A, Sieber W, Studt J, Schuepbach R, Ganter C, Manz M, et al.
J Clin Med . 2023 Apr; 12(8). PMID: 37109212
Therapeutic plasma exchange (TPE) is frequently performed in critical care settings for heterogenous indications. However, specific intensive care unit (ICU) data regarding TPE indications, patient characteristics and technical details are...
8.
Ring A, Nguyen-Strauli B, Wicki A, Aceto N
Nat Rev Cancer . 2022 Dec; 23(2):95-111. PMID: 36494603
In recent years, exceptional technological advances have enabled the identification and interrogation of rare circulating tumour cells (CTCs) from blood samples of patients, leading to new fields of research and...
9.
Ring A, Spataro M, Wicki A, Aceto N
Front Cell Dev Biol . 2022 Jul; 10:929893. PMID: 35837334
Progress in detection and treatment have drastically improved survival for early breast cancer patients. However, distant recurrence causes high mortality and is typically considered incurable. Cancer dissemination occurs circulating tumor...
10.
Ring A, Balakrishna S, Imkamp F, Burkard S, Triet F, Brunschweiler F, et al.
Open Forum Infect Dis . 2022 Jul; 9(6):ofac217. PMID: 35783686
Background: () is an emerging sexually transmitted pathogen among men who have sex with men (MSM). Resistance to recommended antimicrobial agents are of public health concern. Few data exist on...